Zacks Investment Research
23 Jun 2026, 23:17 UTC · 2h ago
Boston Scientific (BSX) Gains As Market Dips: What You Should Know
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Search tags
Zacks Investment Research
23 Jun 2026, 23:17 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Search tags
What the story claims
4 claims · each scored for market impact
Boston Scientific (BSX) is currently assigned a Zacks Rank of #4 (Sell). — A 'Sell' rating from a quantitative ranking system typically signals negative near-term price expectations for investors.
-0.60The Zacks Consensus EPS estimate for Boston Scientific has shifted 0.51% downward over the past month. — Downward revisions in earnings estimates are generally viewed as a bearish indicator for stock performance.
-0.40Boston Scientific's Forward P/E ratio of 13.2 is at a discount compared to its industry average of 17.43. — A lower valuation relative to industry peers can attract value investors, suggesting the stock is undervalued.
+0.30Continue reading
6 related stories
Analysts expect Boston Scientific to report earnings of $0.83 per share and revenue of $5.39 billion in its forthcoming report. — The projected year-over-year growth in both earnings and revenue is positive, though it may be priced in.
Which stocks this story touches
Despite a positive daily move, the company has a Zacks Rank of #4 (Sell) and the stock has fallen over 23% in the past month.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
2h ago
